Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Lantus for Diabetic Patients Treated in Clalit Outpatient Clinics.

Next Previous
Search
Trial Profile

Lantus for Diabetic Patients Treated in Clalit Outpatient Clinics.

Status: Completed
Phase of Trial: Phase III

Latest Information Update: 12 Mar 2012

Price :
$35 *
Note:
  • Adis is an information provider.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
  • A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

  • Drugs Insulin glargine (Primary)
  • Indications Type 2 diabetes mellitus
  • Focus Therapeutic Use
  • Acronyms Lapas-II
  • Sponsors Sanofi

    • Most Recent Events

    • 07 Mar 2012 Planned end date changed from 1 May 2011 to 1 Jan 2012 as reported by ClinicalTrials.gov.
    • 07 Mar 2012 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
    • 01 Mar 2011 Planned end date changed from 1 Nov 2010 to 1 May 2011 as reported by ClinicalTrials.gov.

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:
  • Contacting your organization’s admin about adding this content to your AdisInsight subscription
  • Buying a PDF version of any individual profile
  • Request a free trial
If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top